Accuray to Participate in the 34th Annual J.P. Morgan Healthcare Conference

January 4, 2016 at 4:16 PM EST

SUNNYVALE, Calif., Jan. 4, 2016 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that Joshua H. Levine, president and chief executive officer, is scheduled to present at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 12, 2016 at 4:30pm PDT / 7:30pm ET.  

A live webcast of the presentation will be available on the Investor Relations page of the Company's website at http://www.accuray.com/investors. The webcast replay of the presentation will begin approximately one hour after the conclusion of the live presentation and will be available for approximately 30 days.

About Accuray

Accuray Incorporated (NASDAQ: ARAY) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives.  The Company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments.  For more information, please visit www.accuray.com.

Contacts:




Investors:  

Brian Moore, EVC Group, 310-770-0309 (bmoore@evcgroup.com)

Chris Dailey, EVC Group, 646-445-4801 (cdailey@evcgroup.com)

Doug Sherk, EVC Group, 415-652-9100 (dsherk@evcgroup.com)


Media:         

Beth Kaplan

Public Relations Director, Accuray

408-789-4426

bkaplan@accuray.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/accuray-to-participate-in-the-34th-annual-jp-morgan-healthcare-conference-300198917.html

SOURCE Accuray